AstraZeneca Admits Rare Side Effect Risk In Covishield Vaccine, Sparks Public Concern

AstraZeneca, the pharmaceutical company that produces widely administered COVID-19 vaccines such as Covishield, has acknowledged in a legal dispute that in extremely rare instances, their vaccine may cause serious side effects, including blood clots.

In a recent development, AstraZeneca, the developer of the popular Covishield or Vaxzevria Covid-19 vaccine, has acknowledged that a potential rare side effect is associated with its COVID-19 vaccine which was widely used in India in the second and third wave of COVID-19 pandemic. This admission, made in legal documents submitted to the UK High Court, has sparked public concern and raised questions about vaccine safety.

In a statement issued, the company revealed that a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) can happen after taking the AstraZeneca vaccine. It said, "It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known."

AstraZeneca Admits Its Covishield Vaccine May Lead To Rare Side Effect

This serious condition involves blood clots (thrombosis) occurring alongside a low platelet count (thrombocytopenia). These blood clots can manifest in various parts of the body, including the brain and abdomen.

According to the reports, in a legal defence against Jamie Scott's claim, AstraZeneca admitted to the potential rare side effect associated with its COVID-19 vaccine. This contradicts the company's previous stand in 2023, where it had denied that the vaccine caused TTS at a generic level. The admission may lead to payouts to the victims and their families and has raised concerns about vaccine safety. "It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known...Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence," AstraZeneca said.

With AstraZeneca's vaccine possibly linked to a rare side effect, people are understandably worried, raising questions about the vaccine's safety and the need for strong monitoring of possible side effects. Health experts continue to reassure the public, emphasizing the overarching benefits of getting vaccinated in the battle against Covid-19.

What Is TTS (Thrombosis with Thrombocytopenia Syndrome)?

TTS or Thrombosis with Thrombocytopenia Syndrome rings a bell in the medical sphere given its complexity and potential hazards. We will delve deeper into TTS characteristics, from what it is, its causes, symptoms, diagnosis, and treatment, to how we can prevent it.

TTS, although rare, is a serious condition that couples blood clots with reduced platelet levels. As such, it presents a real threat to health that could lead to serious complications if not addressed quickly. It's important to grasp the mechanisms and risk factors linked with TTS to effectively manage the condition.

AstraZeneca partnered with the Serum Institute of India (SII), the largest vaccine manufacturer globally, to provide the vaccine to the Indian Government.